Suppr超能文献

上市后药物警戒培训

Training in Post-authorization Pharmacovigilance.

作者信息

Ahuja Vivek, Sharma Varun

机构信息

Director-Clinical Operations, CDM & Pharmacovigilance, GVK Biosciences Private Limited.

出版信息

Perspect Clin Res. 2010 Apr;1(2):70-5.

Abstract

Post-authorization pharmacovigilance refers to all the activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems, from the time a product gets the authorization to be marketed in a territory. The ultimate objective of pharmacovigilance is patient safety. To ensure this, any responsible pharmaceutical company will readily vouch for the importance of all these activities, each requiring specific training for efficient and effective execution. Having a well planned job specific training curriculum can help the organization realize its goals and objectives by covering the gaps between current and desired job performance levels and existing competencies of its employees. Apart from this, trainings can help in problem solving, increasing productivity and prepare for and respond to future changes in the organization or job duties. As the pharmaceutical business continues to grow, increasing numbers of skilled people are required to manage resultant increase in pharmacovigilance activities to remain compliant. Thus, the need for training qualified resources to develop into highly skilled pharmacovigilance professionals is the need of the hour. Currently, the supply-demand situation for skilled manpower is highly skewed in favor of the demand, as this field is relatively new in India and elsewhere. It is interesting to note that not many resources, be it internet, literature or books, are available specifically addressing the need of the industry to guide them on training requirements to set up and maintain a competent pharmacovigilance department. This article aims to present a comprehensive perspective on the trainings required in the post authorization scenario pertaining to pharmacovigilance activities and suggest ways to manage these in an efficient way so as to be compliant with the global norms and best practices.

摘要

上市后药物警戒是指从产品在某一地区获得上市许可之时起,与检测、评估、理解和预防不良反应或任何其他药物相关问题有关的所有活动。药物警戒的最终目标是患者安全。为确保这一点,任何负责任的制药公司都会欣然认可所有这些活动的重要性,每项活动都需要进行特定培训才能高效且有效地执行。制定一个精心规划的针对特定工作的培训课程,通过弥补员工当前工作表现水平与期望水平之间以及现有能力之间的差距,能够帮助组织实现其目标。除此之外,培训有助于解决问题、提高生产力,并为组织或工作职责的未来变化做好准备并做出应对。随着制药业务的持续增长,需要越来越多的技术人员来管理因药物警戒活动增加而产生的工作,以保持合规。因此,培养合格资源成为高技能药物警戒专业人员的需求迫在眉睫。目前,由于该领域在印度和其他地方相对较新,熟练劳动力的供需情况严重偏向需求方。值得注意的是,专门针对该行业需求以指导其培训要求以建立和维持一个称职的药物警戒部门的资源,无论是互联网、文献还是书籍,都并不多。本文旨在全面阐述上市后药物警戒活动场景下所需的培训,并提出有效管理这些培训的方法,以便符合全球规范和最佳实践。

相似文献

3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Pharmacovigilance in Israel - tools, processes, and actions.以色列的药物警戒——工具、流程与行动
Isr J Health Policy Res. 2017 Aug 1;6(1):29. doi: 10.1186/s13584-017-0154-3.
9
Pharmacovigilance in pharmaceutical companies: An overview.制药公司的药物警戒:概述
J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S33-7. doi: 10.4103/0976-500X.120945.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验